Antiviral Vector Effects of Ivermectin on COVID-19: An Update

Fatemeh Heidary; Reza Gharebaghi; Mohammed  Lateef; Mustafa  Zain Alabden Mohammed; Sarah  Fawzi Hasan Alshmailawi; Kahtan  Alkhafaji; Rafid  Thamer Albhadili; Hussein  Khalaf Abed Alhairari; Nagham  Fazil Maktoof; Mogdam  Abbas Shafi Alkhshaymee

doi:10.22037/jcma.v6i1.33827

Antiviral Vector Effects of Ivermectin on COVID-19: An Update

authors:

Fatemeh Heidary ^{1
, *} , Reza Gharebaghi ¹ , Mohammed Lateef ² , Mustafa Zain Alabden Mohammed ² , Sarah Fawzi Hasan Alshmailawi ² , Kahtan Alkhafaji ² , Rafid Thamer Albhadili ² , Hussein Khalaf Abed Alhairari ² , Nagham Fazil Maktoof ² , Mogdam Abbas Shafi Alkhshaymee ²

1 International Virtual Ophthalmic Research Center (IVORC), Texas, USA

2 School of Rehabilitation, Shahid Beheshti University of Medical Science, Tehran, Iran

Journal of Cellular & Molecular Anesthesia: Vol.6, issue 1; e150288

published online: January 24, 2021

article type: Letter to the Editor

DOI: https://doi.org/10.22037/jcma.v6i1.33827

how to cite: Heidary F, Gharebaghi R, Lateef M , Zain Alabden Mohammed M , Fawzi Hasan Alshmailawi S , et al. Antiviral Vector Effects of Ivermectin on COVID-19: An Update. J Cell Mol Anesth. 2021;6(1):e150288. https://doi.org/10.22037/jcma.v6i1.33827.

Abstract

Keywords

COVID-19 Antiviral Vector Ivermectin SARS-CoV-2 2019-nCoV severe acute respiratory syndrome coronavirus coronavirus disease 2019

References

1.
References are in the PDF file of the article.

comments

Antiviral Vector Effects of Ivermectin on COVID-19: An Update

Abstract

Keywords

References

Cookie Setting